Bruguerolle Bernard
Medical and Clinical Pharmacology, Faculty of Medicine of Marseille, Université de la Méditerranée, and CHU, Marseilles, France.
Chronobiol Int. 2008 Feb;25(1):1-15. doi: 10.1080/07420520801909247.
The behavior and effects of medications may be modified in the elderly. Factors contributing to such alterations may involve differences in drug pharmacokinetics and response and/or social and economic factors that affect nutrition and compliance to medications. Many studies have been devoted to such factors, but most of them have not taken into account chronopharmacologic data. Indeed, drug-administration time constitutes an additional factor of variability in drug response in the elderly. Biological rhythm-dependent differences in the kinetics and dynamics of medications seem to be diminished or altered with aging. Chronopathological (rhythmic aspects of disease) data in the elderly are of particular importance, taking into account frequently associated diseases, such as chronic obstructive pulmonary disease, cancer, diabetes, glaucoma, hypertension, and inflammatory conditions, among others. Although some chronobiological data are available, chronopharmacologic phenomena have yet to be extensively investigated in the elderly. Most of the sparse studies concern drug chronokinetics, but the data found in the literature do not reveal a clear trend in the age-related changes. Chronokinetic variations in the elderly, compared to young adults, suggest an amplification of the administration-time effects, as demonstrated for digoxin; dampening, as demonstrated for indomethacin; or detection of administration-time effects only in aged but not in young subjects, as found for others medications. Additional studies are needed to better understand the influence of age on the chronokinetics of medications. Moreover, the literature on possible administration-time differences in drug dynamics in the elderly is also very sparse. Altered receptor and/or post-receptor properties and impaired sensitivity of homeostatic mechanisms have yet to be studied from a chronopharmacological point of view. Thus, additional studies are needed to properly understand how drug responses in the elderly may vary in relation to the circadian timing of medications.
药物的行为和作用在老年人中可能会发生改变。导致这种改变的因素可能涉及药物药代动力学和反应的差异,以及影响营养和药物依从性的社会和经济因素。许多研究都致力于这些因素,但大多数研究都没有考虑到时辰药理学数据。事实上,给药时间是老年人药物反应变异性的另一个因素。药物动力学和动态学中与生物节律相关的差异似乎会随着年龄的增长而减弱或改变。考虑到老年人经常伴有慢性阻塞性肺疾病、癌症、糖尿病、青光眼、高血压和炎症等疾病,老年人的时辰病理学(疾病的节律方面)数据尤为重要。虽然有一些时辰生物学数据,但时辰药理学现象在老年人中尚未得到广泛研究。大多数稀疏的研究涉及药物时辰动力学,但文献中发现的数据并未揭示与年龄相关变化的明显趋势。与年轻人相比,老年人的时辰动力学变化表明给药时间效应有所放大,如地高辛所示;减弱,如吲哚美辛所示;或者仅在老年人中检测到给药时间效应,而在年轻人中未检测到,如其他药物所示。需要更多的研究来更好地理解年龄对药物时辰动力学的影响。此外,关于老年人药物动力学中可能存在的给药时间差异的文献也非常稀少。受体和/或受体后特性的改变以及稳态机制敏感性的受损,尚未从时辰药理学的角度进行研究。因此,需要更多的研究来正确理解老年人的药物反应如何因药物的昼夜给药时间而有所不同。